Analytical & Synthesis Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
25
NCT05901194
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma
Phase: Phase 1/2
Role: Collaborator
Start: Jul 10, 2024
Completion: Apr 30, 2027
Loading map...